微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -8.85% | 7.43% | -75.94% | 132/159 | 1.2% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -5.03% | 38.05% | -491.76% | 132/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -0.85% | 75.85% | 95.06% | 123/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -17.21% | -1787.26% | -80.02% | 132/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -9.56% | -508.92% | -17.73% | 135/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -8.12% | -954.74% | -130.68% | 137/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -3.52% | -403.45% | -445.1% | 135/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 1.02% | 108.4% | 164.97% | 97/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -1.57% | 79.23% | -265.26% | 121/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.95% | 115.22% | -18.1% | 104/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.16% | 136.02% | 109.56% | 84/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -12.14% | -346.32% | -60.58% | 127/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -7.56% | -169.04% | -21.15% | 127/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -6.24% | -54.84% | -93.79% | 135/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -3.22% | -60.2% | -18.38% | 128/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -2.72% | -297.1% | 3.2% | 118/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | -2.81% | -2107.14% | 30.27% | 120/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -4.03% | -2115% | -100.5% | 128/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | -2.01% | -161.04% | -245.65% | 118/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 1.38% | 152.47% | 885.71% | 102/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 0.14% | 27.27% | -30% | 97/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.2% | 81.82% | 125.97% | 105/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -0.77% | -144.25% | 70.72% | 92/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -2.63% | -526.19% | -2490.91% | 119/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 0.11% | -95.47% | 0% | 99/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.11% | -90.98% | -93.68% | 105/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.74% | 27.01% | 514.29% | 60/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -0.42% | -132.81% | -117.28% | 120/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 2.43% | 7.52% | 99.18% | 89/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.22% | 52.5% | -10.95% | 93/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.37% | 65.06% | 7.03% | 69/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 1.28% | 1.59% | -43.36% | 111/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.26% | 22.16% | 182.5% | 86/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 0.8% | 29.03% | -3.61% | 95/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.83% | -20.19% | -34.13% | 65/159 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 1.26% | -38.83% | -31.89% | 98/159 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 1.85% | 180.3% | 198.39% | 70/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 0.62% | 82.35% | -40.38% | 78/159 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.04% | 273.33% | -49.51% | 57/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 2.06% | -25.9% | 212.12% | 85/159 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 0.66% | -66.33% | 94.12% | 69/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 0.34% | -70.18% | 156.67% | 72/159 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | -0.6% | -209.09% | -121.58% | 70/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |